Comparison of serum selenium levels among hypertensive and normotensive pregnant women

2016 ◽  
Vol 36 (1) ◽  
pp. 64-69 ◽  
Author(s):  
Alíssia Cardoso da Silva ◽  
Sérgio Hofmeister Martins-Costa ◽  
Edimárlei Gonsales Valério ◽  
José Geraldo Lopes Ramos
PLoS ONE ◽  
2020 ◽  
Vol 15 (8) ◽  
pp. e0238263
Author(s):  
Stephen Chijioke Eze ◽  
Nathan Azubuike Ododo ◽  
Emmanuel Onyebuchi Ugwu ◽  
Joseph Tochukwu Enebe ◽  
Onyema Athanatius Onyegbule ◽  
...  

Author(s):  
Vismaya Kaveri ◽  
Manjula S. K. ◽  
Sheela C. N. ◽  
Anura Kurpad ◽  
Pratibha Dwarkanath

Background: Preeclampsia (PE) is a hypertension disorder condition occurring in 7-10% of all pregnancies. Preeclampsia if unidentified and left untreated is associated with poor maternal and fetal adverse outcomes. The objective of the present study was to characterize maternal serum selenium levels as a predictor of preeclampsia and to correlate dietary selenium intake with serum selenium levels in first trimester of pregnancyMethods: A retrospective case-control study of 107 pregnant women was conducted over 1.5 years at St. John’s Medical College Hospital. On screening for inclusion criteria, at baseline, information on maternal socio-demography, anthropometry, dietary intake and clinical examination was collected. A venous blood sample at baseline and 2nd or 3rdtrimester of pregnancy was collected for estimation of selenium concentrations. Blood pressure was measured at baseline and followed up during pregnancy to select cases and controls. Pregnant women were termed ‘cases’ based on NHBPEP (National High Blood Pressure Education Program) classification and subsequent 22 women with normal blood pressure controlled for age were termed as ‘controls.Results: No statistically significant differences were observed for baseline characteristics, biochemical parameters and blood pressure at recruitment among cases and controls. Cases had significant lower levels of energy (P=0.032) and micronutrients like zinc (P=0.027), selenium (P=0.022), magnesium (P=0.047) at first trimester. The serum selenium levels were significantly higher in cases as compared to the controls (69.2±13.7 vs. 59.6±12.9; P=0.021) at baseline.Conclusions: Our findings suggest that serum selenium levels may not be an independent predictor of preeclampsia. Assessment of other micronutrients, oxidative stress markers and other complementary elements may be useful in predicting preeclampsia.


2016 ◽  
Vol 6 (3) ◽  
pp. 213
Author(s):  
Alíssia Cardoso Silva ◽  
Sergio Martins Costa ◽  
Edimarlei Gonsalez Valerio ◽  
Jose Geraldo Lopes Ramos

2010 ◽  
Vol 6 (2) ◽  
pp. 227
Author(s):  
Mutaz Suyagh ◽  
Peter Sedman ◽  
Prashant Jain ◽  
El-Naseer Salim ◽  
Khaled Hamdan

2010 ◽  
Vol 345 (1-2) ◽  
pp. 23-27 ◽  
Author(s):  
Barbara Kutil ◽  
Petr Ostadal ◽  
Jiri Vejvoda ◽  
Jiri Kukacka ◽  
Jana Cepova ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 991
Author(s):  
Emilia Rogoża-Janiszewska ◽  
Karolina Malińska ◽  
Piotr Baszuk ◽  
Wojciech Marciniak ◽  
Róża Derkacz ◽  
...  

Melanoma is one of the most aggressive human malignancies. The determination of prognostic biomarkers is important for the early detection of recurrence and for the enrollment of the patients into different treatment regimens. Herein, we report the 10-year survival of 375 melanoma patients depending on their serum selenium levels. The study group was followed up from the date of melanoma diagnosis until death or 2020. Patients were assigned to one of four categories, in accordance with the increasing selenium level (I–IV quartiles). The subgroup with low selenium levels had a significant lower survival rate in relation to patients with high selenium levels, HR = 8.42; p = 0.005 and HR = 5.83; p = 0.02, for uni- and multivariable models, respectively. In the univariable analysis, we also confirmed the association between Breslow thickness, Clark classification and age at melanoma prognosis. In conclusion, a low serum selenium level was associated with an increased mortality rate in the 10 years following melanoma diagnosis. Future studies in other geographic regions with low soil selenium levels should be conducted to confirm our findings.


2021 ◽  
Vol 248 (1) ◽  
pp. 45-57
Author(s):  
Pierre Hofstee ◽  
Janelle James-McAlpine ◽  
Daniel R McKeating ◽  
Jessica J Vanderlelie ◽  
James S M Cuffe ◽  
...  

Thyroid disorders are the most common endocrine disorders affecting women commencing pregnancy. Thyroid hormone metabolism is strongly influenced by selenium status; however, the relationship between serum selenium concentrations and thyroid hormones in euthyroid pregnant women is unknown. This study investigated the relationship between maternal selenium and thyroid hormone status during pregnancy by utilizing data from a retrospective, cross-sectional study (Maternal Outcomes and Nutrition Tool or MONT study) with cohorts from two tertiary care hospitals in South East Queensland, Australia. Pregnant women (n = 206) were recruited at 26–30 weeks gestation and serum selenium concentrations were assessed using inductively coupled plasma mass spectrometry. Thyroid function parameters were measured in serum samples from women with the lowest serum selenium concentrations (51.2 ± 1.2 µg/L), women with mean concentrations representative of the entire cohort (78.8 ± 0.4 µg/L) and women with optimal serum selenium concentrations (106.9 ± 2.3 µg/L). Women with low serum selenium concentrations demonstrated reduced fT3 levels (P < 0.05) and increased TPOAb (P < 0.01). Serum selenium was positively correlated with fT3 (P < 0.05) and negatively correlated with TPOAb (P < 0.001). Serum fT4 and thyroid-stimulating hormone (TSH) were not different between all groups, though the fT4/TSH ratio was increased in the low selenium cohort (P < 0.05). Incidence of pregnancy disorders, most notably gestational diabetes mellitus, was increased within the low serum selenium cohort (P < 0.01). These results suggest selenium status in pregnant women of South East Queensland may not be adequate, with possible implications for atypical thyroid function and undesirable pregnancy outcomes.


The Prostate ◽  
2018 ◽  
Vol 78 (4) ◽  
pp. 279-288 ◽  
Author(s):  
Dede N. Ekoue ◽  
Emmanuel Ansong ◽  
Li Liu ◽  
Virgilia Macias ◽  
Ryan Deaton ◽  
...  

1982 ◽  
Vol 15 (6) ◽  
pp. 281-283 ◽  
Author(s):  
Jan Aaseth ◽  
Jan Alexander ◽  
Yngvar Thomassen ◽  
Jan P. Blomhoff ◽  
Sverre Skrede

Sign in / Sign up

Export Citation Format

Share Document